* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download 4-Metabolic & NA Inhibitor(Lec.1&2)
Discovery and development of non-nucleoside reverse-transcriptase inhibitors wikipedia , lookup
Neuropharmacology wikipedia , lookup
MTOR inhibitors wikipedia , lookup
Discovery and development of dipeptidyl peptidase-4 inhibitors wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Gastrointestinal tract wikipedia , lookup
Psychopharmacology wikipedia , lookup
Drug interaction wikipedia , lookup
Discovery and development of cyclooxygenase 2 inhibitors wikipedia , lookup
Discovery and development of direct Xa inhibitors wikipedia , lookup
Discovery and development of cephalosporins wikipedia , lookup
Discovery and development of proton pump inhibitors wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Discovery and development of neuraminidase inhibitors wikipedia , lookup
Discovery and development of ACE inhibitors wikipedia , lookup
Metalloprotease inhibitor wikipedia , lookup
Discovery and development of integrase inhibitors wikipedia , lookup
Reading assignments: Katzung’s Basic & Clinical Pharmacology, 13th Edi ,Ch-46,p807-814; LEARNING OBJECTIVES • D. Inhibitors of folate-dependent pathways • Understand the production and use of folate derivatives in bacterial systems • 1. Sulfonamides – – – – – • 2. Trimethoprim – – – • Understand the function of DNA gyrases, and the effects of their inhibition Know the clinical uses of quinolones and fluoroquinolones Know the adverse effects and potential drug-drug interaction for quinolones F. Nitroimidazoles – – – • Know the mechanism of action of trimethoprim Understand the rationale of combined sulfonamide-trimethoprim chemotherapy Know the clinical uses and adverse effects associated with trimethoprim E. DNA gyrase inhibitors – – – • Know the mechanism of action of sulfonamides Understand the concept of "antimetabolite" Appreciate the role of pharmacokinetics in the action and uses of sulfonamides Know the pharmacokinetic and pharmacodynamic differences among various sulfonamides Know the adverse effects of sulfonamides Understand the mechanism of action of Metronidazole & tinidazole Know the clinical uses Know the adverse effects and potential drug-drug interaction G. Urinary tract antiseptics – Understand the role of pharmacokinetics in the treatment of urinary tract infections D. Inhibitors of folate-dependent pathways 1. Sulfonamides SULFISOXAZOLE SULFAMETHOXAZOLE (1) SULFASALAZINE (SALICYLAZOSULFAPYRIDINE)(2) SODIUM SULFACETAMIDE SILVER SULFADIAZINE (3) CO-TRIMOXAZOLE (SULFAMETHOXAZOLE/TRIMETHOPRIM) (7) 2. Dihydrofolate reductase inhibitors TRIMETHOPRIM (bacteria) (4) PYRIMETHAMINE (protozoa) (5) METHOTREXATE (mammalian) (6) Anti-Metabolites: Anti-Folates Two Classes— Inhibitors of folate synthesis – p-Aminobenzoic acid analogs (PABA) Inhibitors of folate use – dihydrofolate reductase inhibitors • Trimethoprim – bacterial • Pyrimethamine – protozoa • Methotrexate - mammalian Mechanism • PABA analogs Sulfonamides • Enter into a normal metabolic pathway, but then block that pathway • Competitive inhibitor of dihydropteroate synthase • Bacteriostatic Pharmacokinetics • Oral, some topical (burns), rarely IV • Well absorbed from GI, high PPB, well distributed including to CNS • Variable metabolism, depending on drug and patient • Acetylation yields inactive metabolite (less water soluble)→ Crystalluria • Excreted in urine (90% by glomerular filtration) • 10-20x blood concentration in urine Sulfonamides: Clinical Aspects Clinical Use-• Topical for burns--Silver sulfadiazine • Ophthalmic preparations – Sodium sulfacetamide • Urinary Tract Infections-- Uncomplicated, untreated, acute • Ulcerative colitis-- Sulfasalazine, Mesalamine – Not absorbed-- split by gut bacteria reductase to release 5-aminosalicylate • Sulfonamides now are seldom used as single agents-- combine with trimethoprim Sulfonamide alone is almost never used as an antibiotic Adverse Effects-• Allergic reactions-- fever, rash, etc. – Up to 5% incidence – Cross-reactivity with other sulfonamides-- carbonic anhydrase inhibitors, thiazides, furosemide, sulfonylurea hypoglycemics – Crystalluria Sulfonamides: Clinical Aspects Adverse Effects– • Stevens-Johnson syndrome—(Type IV) – Fever, malaise, . . . – Rare, but can be fatal • Hematopoietic effects • Hemolytic anemias-- G6PDH deficiency Drug Interactions Kernicterus in newborns Resistance-• Mutations causing overproduction of PABA • Loss of permeability • New form of dihydropteroate synthetase-discriminates between PABA and sulfonamide Dihydrofolate Reductase Inhibitors • Trimethoprim-- blocks bacterial enzyme • Pyrimethamine-- protozoan enzyme • Methotrexate-- mammalian enzyme Trimethoprim-• Readily absorbed from GI • Wide distribution, including CNS • Excreted in urine • Can be used alone for UTI, but usually combined with a sulfonamide Trimethoprim-Sulfamethoxazole (Cotrimoxazole) • • • • Combination is often bactericidal DOC in Nocardia Mycobacteria Gm-ve Infections (E.Coli, Salmonella,Shihella) • Gm+ve Infections Note: Pneumocystis jiroveci used ( Staph, Strepto, H. Influenzae )to be called Pneumocystis carinii (PCP) Fungus: Pneumocystis jiroveci pneumonia (PCP)-both for prophylaxis (when CD4 count <200) & treatment in HIV infection. • Protozoa : Toxoplasma Gondii (Sulfadiazine + Pyrimethamine) both for prophylaxis (when CD4 count <200) & treatment in HIV infection & in T of STORCH infection. Adverse Effects of Trimethoprim Trimethoprim is 10,000x more effective against bacterial DHFR than against the mammalian enzyme, but still may see "anti-folate" effects • Megaloblastic anemia, leukopenia, granulocytopenia • Treat with folinic acid Co-trimoxazole-- Add typical sulfonamide effects • AIDS patients with Pneumocystis pneumonia (PCP) receiving Co-trimoxazole-– Much higher incidence of adverse effects – Fever, rashes, leukopenia, diarrhea E. DNA gyrase inhibitors NALIDIXIC ACID NORFLOXACIN CIPROFLOXACIN LEVOFLOXACIN GATIFLOXACIN SPAROFLOXACIN MOXIFLOXACIN TROVAFLOXACIN Common ending with ‘floxacin’ Flo-fluorine DNA Gyrase Inhibitors Quinolones Nalidixic Acid-• • • • Prototype quinolone antibiotic Inhibits DNA replication [by inhibiting DNA gyrase (Topoisomerase II)& IV] Pharmacokinetics – Oral administration – Rapidly absorbed, metabolized (Glucuronidated) and excreted in urine Fluoroquinolones-– – – – – – – Norfloxacin Ciprofloxacin Ofloxacin Levofloxacin Gatifloxacin Moxifloxacin Gemifoxacin Note: -floxacin ending • Fluorinated analogues of nalidixic acid • Pharmacokinetics – Well absorbed and distributed after oral administration (Iron,Calcium limit absorption ) – Only 20% is metabolized (liver) – Excreted in urine, blocked by probenecid – Effective systemically after oral dose, parenteral forms also available Fluoroquinolones • Example 1st Generation: norfloxacin; activity against common pathogens that cause urinary tract infections; similar to nalidixic acid • Examples of 2nd Generation: ciprofloxacin, ofloxacin; excellent activity against gram-negative bacteria, including gonococcus, Chlamydia, many grampositive cocci, mycobacteria, and Mycoplasma pneumoniae • Examples of 3rd Generation: levofloxacin, gatifloxacin; less activity against gram-negative bacteria but greater activity against some gram-positive cocci, such as S. pneumoniae, entercocci, and MRSA; good for many drug-resistant respiratory tract infections • Examples of 4th Generation: moxifloxacin, Gemifloxacin; broadest spectrum fluoroquinolones with good activity against anaerobes Activity & Clinical Uses -UTIs particularly when resistant to Cotrimoxazole -STDs/PIDs:Chlamydia (Ofloxacin), Gonorrhea (Cipro,Ofloxacin) -Skin, soft tissue & bone infection by gm-ve organisms (all except norfloxacin) -Diarrhea due to Shigella ,Salmonella, E.coli, Campylobacter (any quinolone) -PNSP (Levofloxacin) Fluoroquinolones Adverse Effects-• Nausea and vomiting • Phototoxicity & rashes (other drugs?) • All quinolone ↑ QT interval • Headaches, dizziness, insomnia • Abnormal liver function tests • Blocks theophylline clearance-- cannot be co-administered • Connective tissue disorders including tendonitis or tendon rapture (in adults), myalgia & leg cramps (in children) – Do not use during pregnancy or in children (Fluorine is the culprit ) Resistance-• Altered (mutated) DNA gyrase • Especially Pseudomonas, Staph, Serratia • No longer recommended for gonococcus because of resistance • Discuss about the rationality of long term use of fluoroquinolones in children , adults or in pregnancy. F. Urinary tract antiseptics NITROFURANTOIN SYSTEMIC AGENTS Urinary Tract Antiseptics • Use systemic agents, which are efficiently cleared in the urine: – Penicillins – Aminoglycosides – Sulfonamides • Resistance and re-infection are common • May need to suppress bacteria for a long time • Common UTI bugs are E.Coli(m/c), staphylococcus saprophyticus ,enterobacter cloacae, proteus mirabilis,klebsiella pneumonae, pseudomonus aeruginosa and serriatia . Nitrofurantoin Mechanism • Unknown, but may involve oxidative stress • Bacteriostatic or bactericidal (depends on microbe) Pharmacokinetics-• Rapidly absorbed (oral), metabolized , and excreted in urine (50% as active drug) • Even IV nitrofurantoin does not have a systemic effect Clinical Use-• UTI, gram positive or gram negative microbes • Most effective if urine pH < 5.5 Adverse Effects-• Anorexia, GI disturbances common, headaches • Occasional hemolytic anemia (oxidative) especially if G6PDH deficient, leukopenia, hepatotoxicity • In renal insufficiency, see systemic toxicity Resistance-• All Pseudomonas, some Proteus are resistant Spectrum coverage of Antibiotics covered in a chart. Antibiotic Sensitivity Overview Antibiotics of Choice for Various Infections Drug Organism (Disease) Amoxicillin, clarithromycin (omeprazole*) Helicobacter pylori (peptic ulcer) Ampicillin Listeria (meningitis) Ceftriaxone, Cefexime Neisseria gonorrhoeae (gonorrhea) Cephalosporins (third-generation) Haemophilus influenzae (pneumonia, meningitis) Klebsiella (meningitis) Doxycycline Borrelia burgdorferi (Lyme disease) Rickettsiae (Rocky Mountain spotted fever) Erythromycin Legionella (legionnaires’ disease) Fluconazole, miconazole, nystatin Candida (candidiasis) Isoniazid, rifampin, ethambutol, pyrazinamide Mycobacterium tuberculosis (tuberculosis) *Omeprazole is not an antibiotic but is used in combination with antibiotics for treatment of H. pylori. Antibiotics of Choice for Various Infections Drug Organism (Disease) Macrolides Mycoplasma pneumoniae (atypical pneumonia) Legionella (legionnaires’ disease) Corynebacterium diphtheriae; Chlamydia Metronidazole Trichomonas (trichomoniasis) Penicillin G Neisseria meningitidis (meningitis) Treponema pallidum (syphilis) Infections caused by streptococci, pneumococci, other meningococci, Bacillus anthracis, Clostridium, Bacteroides (except B. fragilis) Fluroquinolones Campylobacter (diarrhea); Shigella Tetracycline Vibrio cholerae (cholera) Other tetracyclines Chlamydia (pneumonia, lymphogranuloma venereum) Trimethoprim-sulfamethoxazole Salmonella; Shigella (diarrhea) Metronidazole or vancomycin (oral) Clostridium difficile (diarrhea) Prophylactic Use of Anti-infective Drugs Drug Cefazolin Use Surgical procedures Cefoxitin, Cefotetan Surgical procedures where anaerobic infections are common Ampicillin or penicillin Group B streptococcal infections Trimethoprim-sulfamethoxazole Pneumocystis carinii pneumonia (PCP) UTIs Rifampin Haemophilus influenzae type B Meningococcal infection Chloroquine Malaria Isoniazid Tuberculosis Azithromycin Mycobacterium avium complex (MAC) in patients with AIDS Ampicillin or azithromycin or clindamycin Dental procedures in patients with valve abnormalities AIDS = Acquired immunodeficiency syndrome; UTI = urinary tract infection. Antibacterial agents Cell wall synthesis inhibitors Protein synthesis inhibitors Urinary tract antiseptics Nitrofurantoin Inhibitors of folate dependent pathways Systemic agents Sulfonamides Sulfisoxazole Sulfamethoxazole Sulfasalazine Co-trimoxazole Dihydrofolate reductase inhibitors Trimethoprim Pyrimethamine Methotrexate Antimycobacterial drugs Isoniazid Ethambutol Rifampin Rifabutin Pyrazinamide Streptomycin DNA gyrase inhibitors Nalidixic acid Ciprofloxacin Norfloxacin Ofloxacin Levofloxacin -floxain A 44-year-old woman recently exposed to influenza experiences a headache, fever, malaise and a cough. These symptoms subside after 5 days but on the 8th day her cough worsen and she again has a fever. Physical examination reveals signs of pneumonia. Which of the following medications would be most appropriate for the treatment of pneumonia in this patient? A. B. C. D. E. Amantadine Levofloxacin Palivizumab Ribavirin Sulfamethoxazole Answer: B Levofloxacin is a respiratory fluoroquinolone PowerPoint Slides Several of the PowerPoint slides are Copyright © 2002-04, the American Society for Pharmacology and Experimental Therapeutics (ASPET). All rights reserved. Some of slides in this session are from the above mentioned format and are free for use by members of ASPET. Some others are from various sources like text book, recommended books, slides of Dr. S. Akbar (ex. professor, Pharmacology ,MUA). Core concepts of various USMLE High yield review series like Kaplan ,BRS etc. are thoroughly explored & integrated whenever necessary